VectivBio
VECT
#5948
Rank
ยฃ0.78 B
Marketcap
ยฃ12.51
Share price
0.00%
Change (1 day)
188.79%
Change (1 year)

Revenue for VectivBio (VECT)

Revenue in 2022: ยฃ20.29 Million

According to VectivBio's latest financial reports the company's current revenue (TTM ) is ยฃ20.29 Million. In 2022 the company made a revenue of ยฃ20.29 Million an increase over the revenue in the year 2021 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for VectivBio from 2019 to 2022

Annual revenue

Year Revenue Change
2022ยฃ20.29 M
2021N/A
2020N/A
2019N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Organovo
ONVO
ยฃ0.1 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
ยฃ16.21 M-20.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
ยฃ0.76 B 3,646.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
ยฃ0.47 B 2,249.11% Jersey